Upcoming Tocagen IPO To Finance Gene Therapy Clinical Trials By: Benzinga via Benzinga March 21, 2017 at 12:01 PM EDT The biotech firm Tocagen Inc. plans an Initial Public Offering to finance ongoing clinical trials of a technique that uses a weaponized ... Read More >> Related Stocks: Renaissance International IPO ETF